Skip to content

Thrombin

Published: July 26, 2026Updated: July 26, 2026

Thrombin is a topical hemostatic agent used to control bleeding during surgical procedures. It works by directly promoting clot formation at bleeding sites, making it particularly useful when conventional hemostatic methods are insufficient or impractical.

Quick summary

Topical hemostatic agent that promotes blood clotting to control surgical bleeding.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
B02BC06
RxNorm
10528
Generic
Thrombin
Class
atc-b02
Brands
TachoSil, Raplixa, EVARREST, Evicel, Vistaseal, Tisseel, Thrombin-JMI, Evithrom, Recothrom, Artiss
Availability
rx
Lactation
unknown
Routes
topical, nasal
Forms
prefilled syringe, powder, patch, solution, spray
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)topical solution
Usual dose
apply to bleeding surface as needed
Maximum
consult physician
Frequency
intraoperative use only
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)topical solution
Usual dose
apply to bleeding surface as needed
Maximum
consult physician
Frequency
intraoperative use only
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)topical solution
Usual dose
apply to bleeding surface as needed
Maximum
consult physician
Frequency
intraoperative use only
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Thrombin is a topical hemostatic agent applied locally during surgical procedures; systemic absorption is minimal and traditional oral overdose is not applicable
Chronic overdose: Not applicable; topical application in controlled surgical settings prevents cumulative systemic exposure
Immediate actions
Discontinue topical application, monitor for allergic reaction, administer antihistamines or corticosteroids as needed
Antidote
No specific antidote; treat symptomatically(Supportive care is mainstay of treatment)
Poison Control: 1-800-222-1222

Special Populations

10 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

avoid unless benefits outweigh potential risks to fetus

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use only during surgical procedures when benefit justifies risk

Monitor

fetal monitoring during procedures

Use with caution and monitor for adverse effects.

✓

lactation

breastfeeding
safe
FDA Category
C
Dose Adjustment

no adjustment needed

Key Recommendations

compatible with breastfeeding as topical application has minimal systemic absorption

Monitor

none required

✓

geriatric

elderly
safe
FDA Category
C
Dose Adjustment

no specific adjustment

Key Recommendations

use standard dosing; monitor for thromboembolic events particularly in patients with cardiovascular comorbidities

Monitor

monitor for signs of thrombosis or embolism

⚠

pediatric_age

neonates
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

use with extreme caution in neonates especially premature infants due to developing coagulation system

Monitor

close monitoring of coagulation parameters

Use with caution and monitor for adverse effects.

✓

pediatric_age

children
safe
FDA Category
C
Dose Adjustment

no specific adjustment

Key Recommendations

can be used in pediatric patients with standard dosing for indicated procedures

Monitor

standard surgical monitoring

✓

renal_impairment

mild to moderate
safe
FDA Category
C
Dose Adjustment

no adjustment needed

Key Recommendations

topical application results in minimal systemic absorption; no dose modification required

Monitor

standard monitoring

✓

renal_impairment

severe
safe
FDA Category
C
Dose Adjustment

no adjustment needed

Key Recommendations

use standard dosing as topical thrombin has negligible systemic absorption

Monitor

standard monitoring

✓

hepatic_impairment

mild to moderate
safe
FDA Category
C
Dose Adjustment

no adjustment needed

Key Recommendations

topical use; limited systemic absorption makes dose adjustment unnecessary

Monitor

standard monitoring

⚠

hepatic_impairment

severe
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

coagulation factor deficiency may exist; monitor coagulation parameters before and after use

Monitor

monitor coagulation profile and for excessive bleeding or clotting

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1990s

General prescribing information

drug_classFDA
2023

Drug class

Value:Hemostatic agent

Topical thrombin hemostatic agents

usageMedical guidelines
2023

Common uses

Value:Surgical hemostasis

Control of surgical bleeding

mechanismFDA
2023

Mechanism of action

Value:Converts fibrinogen to fibrin

Hemostatic mechanism

Used to control mild to moderate bleeding during surgical procedures, particularly when conventional techniques like suturing or ligature are ineffective, impractical, or not possible. Commonly used in cardiovascular, abdominal, orthopedic, and neurosurgical procedures.

When applied to a bleeding wound surface, thrombin converts fibrinogen to fibrin, which polymerizes to form a stable fibrin clot. This mechanical seal stops bleeding by providing a scaffold for platelet aggregation and clot formation at the site of application.

For topical use only—do not inject intravascularly. Should not be used in patients with known hypersensitivity to thrombin or fibrinogen. May cause immune responses in some patients. Should be stored according to manufacturer specifications and used within specified timeframes after reconstitution.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy